title: Non-ergot dopamine agonist-induced sleep attacks.
abstract: Two patients with Parkinson's disease received treatment with ropinirole and/or pramipexole, during which both experienced sleep attacks. These attacks may be a class effect of non-ergot dopamine agonists. Health care professionals should be aware of the potential of these agents to cause sleep attacks and caution patients about this potentially life-threatening adverse effect.
authors.affiliation: Division of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, USA.
authors.forename: M
authors.initials: M
authors.lastname: Ryan
authors.forename: J T
authors.initials: JT
authors.lastname: Slevin
authors.forename: A
authors.initials: A
authors.lastname: Wells
mesh_terms: D000368:Aged; D052160:Benzothiazoles; D018491:Dopamine Agonists / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D000077487:Pramipexole; D012893:Sleep Wake Disorders / Q000139:chemically induced*; D013844:Thiazoles / Q000009:adverse effects*
chemical_list: D052160:Benzothiazoles; D018491:Dopamine Agonists; D007211:Indoles; D013844:Thiazoles; C046649:ropinirole; D000077487:Pramipexole